Article Information
History
- May 16, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Roux-Cil Ferreira1,
- Steven J. Reynolds2,3,4,
- Adam A. Capoferri3,
- Owen Baker3,
- Erin E. Brown2,
- Ethan Klock3,
- Jernelle Miller3,
- Jun Lai3,
- Sharada Saraf2,
- Charles Kirby3,
- Briana Lynch2,
- Jada Hackman2,
- Sarah N. Gowanlock5,
- Stephen Tomusange4,
- Samiri Jamiru4,
- Aggrey Anok4,
- Taddeo Kityamuweesi4,
- Paul Buule4,
- Daniel Bruno6,
- Craig Martens6,
- Rebecca Rose7,
- Susanna L. Lamers7,
- Ronald M. Galiwango4,
- Art F. Y. Poon1,5,
- Thomas C. Quinn2,3,
- Jessica L. Prodger5,8,* and
- Andrew D. Redd2,3,9,*,†
- 1Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada
- 2Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
- 3Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD
- 4Rakai Health Sciences Program, Kalisizo, Uganda
- 5Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, London, Ontario
- 6Genomic Unit, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT
- 7BioInfoExperts, LLC, Thibodaux, LA
- 8Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario
- 9Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- ↵†Correspondence to: Andrew D. Redd, Johns Hopkins University; Rangos Building Room 540, 851 N Wolfe St, Baltimore MD, 21205, Email: reddandrew{at}niaid.nih.gov
↵* ADR and JLP contributed equally on this study
Posted May 16, 2023.
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen
